Guidance on nitrosamine impurities in medications.: H164-327/2022E-1-PDF

"Evaluating and managing the risks of N-nitrosamine impurities in human pharmaceutical, biological and radiopharmaceutical products"--Cover.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.914730&sl=0

Publication information
Department/Agency Canada. Health Canada, issuing body.
Title Guidance on nitrosamine impurities in medications.
Publication type Monograph
Language [English]
Other language editions [French]
Later edition Guidance on nitrosamine impurities in medications. April 17, 2023
Earlier edition Guidance on nitrosamine impurities in medications. April 2022
Format Electronic
Electronic document
Note(s) Cover title.
"Date adopted: September 1, 2022. Effective date: September 1, 2022."
Issued also in French under title: Lignes directrices sur les impuretés de nitrosamine dans les médicaments.
Includes bibliographical references.
Publishing information Ottawa, ON : Health Canada = Santé Canada, 2022.
©2022
Description 1 online resource (iii, 25 pages)
ISBN 9780660451770
Catalogue number
  • H164-327/2022E-1-PDF
Departmental catalogue number 220382
Subject terms Nitrosoamines -- Risk assessment -- Canada.
Drugs -- Risk assessment -- Canada.
Biologicals -- Risk assessment -- Canada.
Radiopharmaceuticals -- Risk assessment -- Canada.
Pharmaceutical policy -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: